THINK Surgical's TMINI Handheld Robotic Platform Expands FDA Clearance to Include Medacta's GMK Sphere and SpheriKA Knee Implants

Source: MedRobot; Editor: Sophia

Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.

Registration is about to close! The 2nd Global Surgical Robotics Conference

Endoscopic Surgical Robot Products Course

# Reach Cooperation

Recently, Medacta Group SA (“Medacta”, SIX: MOVE) announced a collaboration with THINK Surgical.Medacta provides GMK Sphere and GMK SpheriKA products to THINK Surgical. GMK SpheriKA is the world's first knee implant specifically designed for kinematic alignment.

After being approved by the U.S. FDA,GMK SphereAndSpheriKAThe knee joint system has now been added to THINK Surgical's ID-HUB™.

• On October 23, 2023, THINK Surgical announced that its TMINI™ handheld orthopedic micro-robot has received FDA 510(k) clearance in the United States, allowing the use of orthopedic implants provided by three other implant manufacturers.

Related Reading:THINK Surgical: FDA Expands Approval! Handheld Orthopedic Micro Robot

• On February 12, 2024, THINK Surgical announced that it would enter into a new cooperation agreement with German company Waldemar Link GmbH & Co. KG (LINK), which is renowned for its innovative joint replacement solutions.

Related Reading:Partnership Achieved! Handheld Micro Robots Expand Applications

• On July 9, 2024, THINK Surgical, Inc. announced that it has signed a cooperation agreement with Signature Orthopaedics.

GMK Sphere Medial Stabilized Total Knee Implant is designed to provide maximum functional stability, aiming to improve satisfaction in TKA/TKR patients during daily living activities and reduce postoperative knee pain.

GMK SpheriKA continues the ball-and-socket design of GMK Sphere, offering patients a new type of implant that provides a more natural and stable feeling during daily activities, replicating the motion patterns of a healthy knee.

In addition, the GMK SpheriKA knee replacement prosthesis features optimized femoral coverage and patellar tracking, making it suitable for kinematic alignment surgery. It is the first implant on the market specifically designed for KA technology.

# About Medacta

Medacta (SIX: MOVE), a publicly traded company headquartered in Switzerland, focuses on the orthopedic sector, particularly in joint replacement, spinal surgery, and sports medicine.

The company will AMIS^®(A minimally invasive technique) system for hip replacement, MyKnee^®Patient-matching technology for total knee arthroplasty, AMIS has been used in over 50,000 hip surgeries worldwide.

In addition, Medacta's NextAR Augmented Reality (AR) surgical platform has obtained registration certification. The platform is suitable for knee, shoulder, and spine applications, and successfully performed a reverse shoulder arthroplasty using NextAR Shoulder in July 2021.

Medacta Officially Begins Commercialization of 3D Femoral Conical Wedge for Revision Knee Arthroplasty After Receiving FDA Approval and CE Marking

Medacta also leverages its orthopedic expertise and deep understanding of the human body to develop the advanced "MySolutions" technology, which provides highly personalized preoperative planning and implant placement methods for surgeons through the creation of advanced personalized kinematic models and 3D planning tools for the hip, and can be applied to knee, shoulder, and spine surgeries.

Well-known Surgical Robot Companies in China: